Campa et al., 2013 - Google Patents
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortiumCampa et al., 2013
- Document ID
- 8505111937838020304
- Author
- Campa D
- Rizzato C
- Capurso G
- Giese N
- Funel N
- Greenhalf W
- Soucek P
- Gazouli M
- Pezzilli R
- Pasquali C
- Talar-Wojnarowska R
- Cantore M
- Andriulli A
- Scarpa A
- Jamroziak K
- Delle Fave G
- Costello E
- Khaw K
- Heller A
- Key T
- Theodoropoulos G
- Malecka-Panas E
- Mambrini A
- Bambi F
- Landi S
- Pedrazzoli S
- Bassi C
- Pacetti P
- Piepoli A
- Tavano F
- di Sebastiano P
- Vodickova L
- Basso D
- Plebani M
- Fogar P
- Büchler M
- Bugert P
- Vodicka P
- Boggi U
- Neoptolemos J
- Werner J
- Canzian F
- Publication year
- Publication venue
- Digestive and liver disease
External Links
Snippet
Pancreatic cancer is the fourth leading cause of cancer deaths in the European Union and in the USA, but little is known about its genetic susceptibility. The PANcreatic Disease ReseArch (PANDoRA) consortium was established to unite the efforts of different research …
- 208000008443 Pancreatic Carcinoma 0 title abstract description 44
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Campa et al. | Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium | |
Klein et al. | Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer | |
Orloff et al. | Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma | |
Prescott et al. | Epidemiologic evidence for a role of telomere dysfunction in cancer etiology | |
Wang et al. | Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer | |
Rizzato et al. | ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium | |
Rao et al. | Accelerated leukocyte telomere erosion in schizophrenia: evidence from the present study and a meta-analysis | |
Ren et al. | Identification and validation of a novel redox-related lncRNA prognostic signature in lung adenocarcinoma | |
Dong et al. | Potentially functional polymorphisms in DNA repair genes and non‐small‐cell lung cancer survival: a pathway‐based analysis | |
Han et al. | Genome-wide association study in East Asians identifies two novel breast cancer susceptibility loci | |
Bradford et al. | Whole transcriptome profiling of patient-derived xenograft models as a tool to identify both tumor and stromal specific biomarkers | |
Samuel et al. | Genome-wide DNA methylation analysis reveals epigenetic dysregulation of microRNA-34A in TP53-associated cancer susceptibility | |
Wang et al. | Mitochondrial DNA mutations in diabetes mellitus patients in Chinese Han population | |
Fanale et al. | Prevalence and spectrum of germline BRCA1 and BRCA2 variants of uncertain significance in breast/ovarian cancer: mysterious signals from the genome | |
Wang et al. | Analysis of polymorphisms in genes associated with the FA/BRCA pathway in three patients with multiple primary malignant neoplasms | |
Yang et al. | A novel defined pyroptosis-related gene signature for predicting prognosis and treatment of glioma | |
Jin et al. | Association of the miR-17-5p variants with susceptibility to cervical cancer in a Chinese population | |
Yiannakouris et al. | Genetic predisposition to coronary heart disease and stroke using an additive genetic risk score: a population-based study in Greece | |
Xu et al. | Prognostic nomogram for acute myeloid leukemia patients with biallelic CEBPA mutations | |
Xu et al. | Tumor microenvironment-associated immune-related genes for the prognosis of malignant pleural mesothelioma | |
Huang et al. | ADAMTSL2 is a potential prognostic biomarker and immunotherapeutic target for colorectal cancer: Bioinformatic analysis and experimental verification | |
Zhang et al. | Identification and validation of a novel cuproptosis-related gene signature in multiple myeloma | |
Jiang et al. | Transcription factor 21 (TCF21) rs12190287 polymorphism is associated with osteosarcoma risk and outcomes in East Chinese population | |
Ünal et al. | Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk | |
Arnar et al. | Genetics of common complex diseases: a view from Iceland |